A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract

Oncology ◽  
2010 ◽  
Vol 78 (5-6) ◽  
pp. 356-360 ◽  
Author(s):  
Niki Karachaliou ◽  
Aris Polyzos ◽  
Nikolaos Kentepozidis ◽  
Stylianos Kakolyris ◽  
Nikolaos Ziras ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Cancer ◽  
Line Treatment ◽  
First Line ◽  
Multicenter Phase ◽  
First Line Treatment

scholarly journals Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

Cancer ◽  
2004 ◽  
Vol 100 (2) ◽  
pp. 279-287 ◽  
Author(s):  
Emilio Bajetta ◽  
Maria Di Bartolomeo ◽  
Luigi Mariani ◽  
Antonio Cassata ◽  
Salvatore Artale ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Line Treatment ◽  
Metastatic Colorectal Carcinoma ◽  
First Line ◽  
Multicenter Phase ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document